Moderna, IBM turn to quantum computing in hunt for new mRNA medicines
Moderna plans to build a “quantum-ready workforce,” in CEO Stéphane Bancel’s words, with the help of global tech conglomerate IBM, the companies said Thursday morning.
As the Cambridge, MA-based biotech expands beyond Covid-19 vaccines and into flu, RSV and other disease areas, Moderna plans to employ quantum computing and generative AI to make new mRNA medicines, optimize logistics and do what a “classical computer” can’t. Generative AI is now dinner-party fodder thanks to the arrival of ChatGPT late last year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.